Please login to the form below

Mosquirix

This page shows the latest Mosquirix news and features for those working in and with pharma, biotech and healthcare.

Dosing of GSK's malaria vaccine due to start in 2018

GSK's vaccine – also known as Mosquirix – is considered to have limited efficacy, but the sheer scale of the public health problem posed by malaria in some areas of the world

Latest news

Malaria vaccine is first to provide 'sustained protection'

The results have been published in the journal Nature Medicine. That data looks pretty good when compared to trials of the Mosquirix malaria vaccine developed by GlaxoSmithKline (GSK) - which has already ... Mosquirix (formerly known as RTS, S) also
Shire and Baxalta drugs among CHMP's latest recommendations

Mosquirix outside the EU.
World first as CHMP backs GSK malaria vaccine Mosquirix

World first as CHMP backs GSK malaria vaccine Mosquirix. The EMA's scientific advisers recommend its useoutside Europe. ... The CHMP and GSK's biologics unit agreed measures to ensure the safety and effectiveness of Mosquirix is continuously monitored
GSK seeks approval for first malaria vaccine

Submits marketing application to European Medicines Agency
GSK’s 2011 sales dip but Witty confident for 2012

The remaining three products are skin cancer therapy BRAF, HIV/AIDS treatment dolutegravir and malaria vaccine Mosquirix.

More from news
Approximately 3 fully matching, plus 5 partially matching documents found.

Latest Intelligence

Deal Watch January 2018

GSK's malarial vaccine, Mosquirix which also contains Agenus’QS-21 Stimulon, was approved for use by the EMA in 2015.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Market Access Consultant - Greater Manchester: Negotiable

Healthcare PR Senior Account Manager: Salary TBC

Account Manager- 4 days per week or full-time: Salary TBC

Leadership opportunity, Pricing & Market Access, UK, Substan...: Substantial six figure package

Medical Writer - Creative and Scientific Projects: DOE

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Senior/ Market Access Consultant, UK, HOME BASED, £50-60K: Excellent package

Senior Medical Writer: Salary is DOE

Senior Medical Writer, MedComms Agency: £40 - 55, 000 according to skills and experience benefits

Senior Medical Writer, Principal Medical Writer, Scientific Dire...: £40000 - £75000 Bonus Benefits

Account Director, Medical Communications & Events: £50 - 65, 000 according to skills and experience benefits

Associate Scientific Director: Salary TBC

Account Director, Healthcare Advertising Agency: Salary TBC

Systematic Review Lead- London: Negotiable

Account Director or Senior Account Director: Salary TBC

Senior Account Manager / Account Director - Medical Education – ...: Salary TBC

Account Director - Award Winning Healthcare Advertising Agency -...: £50000 - £68000

Healthcare PR Director: £100, 000 – £120, 000 benefits

Sudler London - Senior Medical Writer: Competitive

Senior Strategist/ Planner, Healthcare Marketing, London: Excellent package

Account Manager, Healthcare Advertising: £30 - 38, 000 (or -)

Principal Medical Writer / Editorial Director – Medical Communic...: £60, 000 - £80, 000

Deputy Managing Director – Healthcare PR – Global Agency: Negotiable

Account Director, Healthcare Communications Agency: £54, 000- £60, 000

Subscribe to our email news alerts

PMHub

Add my company

Digitas Health

Digitas Health is the only digital-at-the-core brand agency designed to connect today's healthcare brands with today's healthcare consumers and professionals....

Latest intelligence

PM Society Digital Awards – the power of together: Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduce anyone in four simple steps: You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government: GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....